Amgen, Regeneron, Sanofi endocrine/metabolic news

Amgen filed a suit in the U.S. District Court for the District of Delaware alleging that alirocumab from Regeneron and Sanofi infringes Amgen's U.S. Patent Nos. 8,563,698; 8,829,165; and 8,859,741 cov...